Ribociclib
Interviews and expert commentary tagged “Ribociclib” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
John P. Crown MD MBA: ESMO 2025, Berlin: Adjuvant Ribociclib Brought Longer Freedom from Metastases for Patients with HR+/HER2- Early Breast Cancer: NATALEE Five Year Outcomes
John P. Crown MD MBA: ESMO 2025, Berlin: Adjuvant Ribociclib Brought Longer Freedom from Metastases for Patients with HR+/HER2- Early Breast Cancer: NATALEE Five Year Outcomes
24 October 2025
0:00
Audio Journal of Oncology
Ribociclib Aids First-Line Endocrine Therapy in Premenopausal Advanced Breast Cancer
BARCELONA—More pre-menopausal women who have estrogen receptor (ER) positive advanced breast cancer could be spared chemotherapy—according to latest findings from the MONALEESA-7 double-blind randomiz
18 April 2018
8:00